Bucog, Ea-mie .

HRN: 13-52-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2026
CO-AMOXICLAV 625MG (TAB)
01/22/2026
01/28/2026
PO
625mg
BID
Urinary Tract Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: